IP Library Granted Patent US 10,632,078
Granted Patent B2
US 10,632,078 · App. 16/116,216 · Granted Apr 28, 2020

Rapidly disintegrating gelatinous coated tablets

Inventors: Roger A Rinker (Hatfield, PA); Nicholas J. Casale (Horsham, PA); James H. Comly (Downingtown, PA); Brenda Pollock (Cupertino, CA); Johan Geerke (Los Altos, CA); Martin Costello (Fremont, CA); Dennis Wieand (Coopersburg, PA); Kishor Parekh (Horsham, PA)
A61K9/2886A61K9/2072A61K9/286A61K9/2866A61K9/2873A61K31/167A61K45/06
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,632,078
App. No.
16/116,216
Granted
Apr 28, 2020
Kind
B2
Abstract

The present invention relates to an improved gelatinous coated dosage form having two end regions coated with gelatinous materials and an exposed circumferential band. Openings are provided in at least the exposed band to reveal the core material. The invention also relates to methods for manufacturing such gelatinous coated dosage forms.

Claims (7)

1. A method of treatment, comprising administering a dosage form, wherein said dosage form comprises:

a) a core having an exterior surface and first and second ends, wherein the core comprises one or more pharmaceutically active ingredients, cellulose or a derivative of cellulose, pregelatinized starch, and magnesium stearate;

b) a first gelatinous coating over at least part of the core; and

c) a second gelatinous coating over at least part of the core;

wherein the first and second gelatinous coatings are provided on the first and second ends of the core;

wherein the first and second gelatinous coatings form a gap through which the core is exposed, wherein the gap has a width of greater than 7% to about 25% of the length of the elongated core, wherein the gap does not effect swallowability of the dosage form; and

wherein the first and second gelatinous coatings each comprise gelatin.

Assignments (6)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 19, 2023
From: JOHNSON & JOHNSON CONSUMER INC.
To: JOHNSON & JOHNSON CONSUMER INC.
Reel/Frame 062438/0372 →
CERTIFICATE OF CONVERSION Recorded Jan 19, 2023
From: JOHNSON & JOHNSON CONSUMER INC.
To: JOHNSON & JOHNSON CONSUMER INC.
Reel/Frame 062438/0521 →
MERGER Recorded Jan 27, 2022
From: CHENANGO ZERO LLC
To: CHENANGO TWO LLC
Reel/Frame 058888/0133 →
MERGER AND CHANGE OF NAME Recorded Jan 27, 2022
From: CHENANGO TWO LLC; CURRAHEE HOLDING COMPANY INC.
To: JOHNSON & JOHNSON CONSUMER INC.
Reel/Frame 058888/0210 →
MERGER Recorded Jan 27, 2022
From: JOHNSON & JOHNSON CONSUMER INC.
To: CHENANGO ZERO LLC
Reel/Frame 059618/0521 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 11, 2019
From: RINKER, ROGER A.; CASALE, NICHOLAS J.; COMLY, JAMES H.; POLLOCK, BRENDA; COSTELLO, MARTIN; WIEAND, DENNIS; GEERKE, JOHAN; PAREKH, KISHOR
To: JOHNSON & JOHNSON CONSUMER INC.
Reel/Frame 050019/0964 →
Continuity (5)
Continuation 14833839 · Aug 24, 2015
Continuation 14335228 · Jul 18, 2014
Continuation 12970079 · Dec 16, 2010
Division 10756528 · Jan 13, 2004
Related Publication 20180369152A1 · Dec 27, 2018